[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"breast-asymmetry\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:breast-asymmetry":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100607279","wearable-ultrasound-patch-for-breast-imaging-100607279",false,"NCT07186491","Wearable Ultrasound Patch for Breast Imaging","Exploring the Application of a Wearable Ultrasound (US) Patch Device for Breast Imaging","Inclusion Criteria:\n\n* Investigators will exclusively enroll patients who have undergone conventional US imaging for their breasts within the past month or are scheduled to undergo it within the upcoming month.\n* Patients with a history of breast cancer or prior breast surgery can also be enrolled\n* Female gender\n* Ages between 18 and 85 years old\n* Being able to understand, communicate, give valid consent to the study, and be understood by researchers\n\nExclusion Criteria:\n\n* Having significant health problems (such as chronic or acute cardiovascular diseases, skin diseases) physical and\u002For behavioral health disabilities limiting participants' ability to follow directions and complete research related activities.\n* Being pregnant\n* Not having intact, healthy breast skin (having open scars or wounds around the location of the breast)",true,"FEMALE","18 Years","85 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn if a wearable ultrasound (US) patch can provide reliable whole-breast imaging and accurately detect breast lesions in patients undergoing breast health evaluation. The main questions it aims to answer are:\n\n* How well does the US-patch detect breast lesions in breasts of different shapes, sizes, and tissue densities?\n* Are there any side effects or discomfort from using the US-patch?\n\nResearchers will compare results from the wearable US-patch to conventional ultrasound to see if the patch provides specific and sensitive findings.\n\nParticipants will:\n\n* Have breast imaging performed with the wearable US-patch, which is applied directly to the breast and secured with a sports bra.\n* Use a guiding software application that helps correctly position the patch.\n* Complete the imaging session in less than 15 minutes, performed by study personnel.",[28,29,30,31],"Breast Cancer","Breast Abnormalities","Breast Lesion","Breast Asymmetry",[33,28,34,30,35],"Breast Imaging","Wearable Imaging","Ultrasound","NOT_YET_RECRUITING","2026-03-04",{"date":39,"type":40},"2026-03-06","ACTUAL",{"date":42,"type":22},"2026-04-01",{"date":44,"type":22},"2027-03",{"name":46,"class":47},"Massachusetts General Hospital","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":4,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":79},"100546925","oncologic-cosmetic-and-patient-reported-outcomes-in-value-based-breast-surgery-oncopro-value-100546925","NCT06401304","Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)","Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery. A Multicentre, Cohort Study","OncoPROValue-1","Inclusion Criteria:\n\n1. Female aged above 18 years.\n2. Signed and dated written informed consent before the start of specific protocol procedures; oral consent for the participants of the quality control retrospective cohort study before accepting to partake a telephone interview.\n3. Patients with invasive breast cancer (IBC) or ductal cancer in situ (DCIS) or unclear lesions mandating surgical excision or benign lesions amenable for surgical resection with BCS.\n4. ECOG performance status 0-2.\n\nExclusion Criteria\n\n1. Life expectancy of less than 6 months\n2. Non candidate for breast conservation\n3. Inability to understand given information and give informed consent or undergo study procedures",{"count":58,"type":22},1200,"OBSERVATIONAL","The study aspires to provide outcomes on surgery, quality of life and time-to-event outcomes following the development and validation of a standardised surgical assessment tool in a shared decision-making framework for patients with pre-invasive or invasive breast cancer with breast conservation.",[28,62,63,31],"Breast Carcinoma in Situ","Breast Cancer Invasive",[65,66,67,68],"Oncoplastic breast conservation","Breast Conserving Surgery","Patient reported outcomes","Shared decision making","RECRUITING","2024-05-02",{"date":72,"type":40},"2024-05-06",{"date":74,"type":40},"2020-01-01",{"date":76,"type":22},"2032-12-30",{"name":78,"class":47},"Uppsala University",3]